BTX161

1 Cited Publications
Customer Review

Based on 1 publication(s) in Google Scholar

BTX161, a thalidomide analog, is an effective CKIα degrader. BTX161 mediates human AML cell CKIα degradation more effectively than lenalidomide and activates the DNA damage response (DDR) and p53, while stabilizing p53 antagonist MDM2.

For research use only. We do not sell to patients.

  • Purity: 99.20%
  • CAS No.: 2052301-24-1
  • Formula: C15H16N2O3
  • Molecular Weight:272.30
  • Storage:
    Powder   -20°C, 3 years , 4°C, 2 years ; In solvent   -80°C, 6 months , -20°C, 1 month
  • Biological Activity
  • Chemical Information
  • Solvent & Solubility
  • Purity & Documentation
  • References
  • Help & FAQs

Publications Citing Use of MedChemExpress (MCE) BTX161

More

All Casein Kinase Isoforms

More
100 mg
Get Quote In-stock
Please select quantity
Price: USD 0.00